Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26375676
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26375676
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 PLoS+One
2015 ; 10
(9
): e0138384
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary
Arterial Hypertension
#MMPMID26375676
Yamamura A
; Ohara N
; Tsukamoto K
PLoS One
2015[]; 10
(9
): e0138384
PMID26375676
show ga
Idiopathic pulmonary arterial hypertension (IPAH) is a rare and progressive
disease of unknown pathogenesis. Vascular remodeling due to excessive
proliferation of pulmonary arterial smooth muscle cells (PASMCs) is a critical
pathogenic event that leads to early morbidity and mortality. The excessive cell
proliferation is closely linked to the augmented Ca2+ signaling in PASMCs. More
recently, we have shown by an siRNA knockdown method that the Ca2+-sensing
receptor (CaSR) is upregulated in PASMCs from IPAH patients, involved in the
enhanced Ca2+ response and subsequent excessive cell proliferation. In this
study, we examined whether pharmacological blockade of CaSR attenuated the
excessive proliferation of PASMCs from IPAH patients by MTT assay. The
proliferation rate of PASMCs from IPAH patients was much higher (~1.5-fold) than
that of PASMCs from normal subjects and patients with chronic thromboembolic
pulmonary hypertension (CTEPH). Treatment with NPS2143, an antagonist of CaSR or
calcilytic, clearly suppressed the cell proliferation in a
concentration-dependent manner (IC50 = 2.64 ?M) in IPAH-PASMCs, but not in normal
and CTEPH PASMCs. Another calcilytic, Calhex 231, which is structurally unrelated
to NPS2143, also concentration-dependently inhibited the excessive proliferation
of IPAH-PASMCs (IC50 = 1.89 ?M). In contrast, R568, an activator of CaSR or
calcimimetic, significantly facilitated the proliferation of IPAH-PASMCs (EC50 =
0.33 ?M). Similar results were obtained by BrdU incorporation assay. These
results reveal that the excessive PASMC proliferation was modulated by
pharmacological tools of CaSR, showing us that calcilytics are useful for a novel
therapeutic approach for pulmonary arterial hypertension.